February 13, 2024

Paul Sanger: I am Paul Sanger for the Finance News Network, and today I’m talking with Blu Glass (ASX:BLG). It has a market cap around 70 million. The company has been developing leading edge semiconductor manufacturing technology and devices for more than a decade. It is a global provider to the gallium nitride photonics industry, delivering […]

Seven Group Holdings (ASX:SVW), led by Kerry Stokes, has once again demonstrated its resilience in the face of economic fluctuations, announcing record revenue and earnings for the December half-year period. However, in a move reflecting its strategic approach to financial management, Seven Group has opted to maintain its interim dividend at 23 cents per share

Fletcher Building (ASX:FBU), a prominent player in the construction industry, is poised to resume trading on the Australian Securities Exchange (ASX) at 10 am today, marking the end of a two-day halt initiated after a rapid 6% drop in shares within just 8 minutes. The company’s decision to halt trading came in the wake of

Investors, especially on Wall Street and later today in Australia, received the rude shock they deserved from the slight fall in US Consumer Price Inflation in January. US headline inflation slowed to 3.1% in January, down from 3.4% in December. It was a smaller-than-expected drop, challenging market expectations that the Federal Reserve will begin cutting

So much for all the bullish forecasts about the Commonwealth Bank’s (ASX:CBA) interim result. Yes, a cash profit of just over $5 billion was reported, but the underlying data—so beloved by analysts looking for a ‘good story’—wasn’t pretty. The bank’s statutory profit showed a larger 8% fall to $4.837 billion. The weak result, analysts had

US stocks dropped on Tuesday after hotter-than-expected inflation data for January spiked Treasury yields and raised doubts that the Federal Reserve would be able to cut rates several times this year, a key part of the bull case for the equity market. The Dow Jones Industrial Average lost 524.63 points, or 1.35 per cent, to

Australian shares experienced a second consecutive decline, driven by CSL’s disappointing outlook, while investors awaited US inflation data for insights into potential Federal Reserve interest rate adjustments. Notable movements occurred during the reporting season, particularly in healthcare where CSL’s weaker outlook overshadowed profit growth, causing the benchmark to close 0.2 percent lower at 7603.6. Consumer-related

Shares of the online employment giant, Seek (ASX:SEK), took a dive of 10% during early trading as investors swiftly expressed disapproval of its interim results reflecting the repercussions of a sluggish labour market. However, as Tuesday’s session unfolded, the initial loss mitigated to around 4% as investors and analysts revisited the report’s intricacies, finding it

Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses the significance of the company’s binding offtake agreement with Panasonic. Paul Sanger: I’m Paul Sanger for the Finance News Network, and today I am talking with NOVONIX (ASX:NVX). They have a market cap of around $335m. NOVONIX provides revolutionary solutions that enable the adoption of clean energy

Blood products behemoth CSL (ASX:CSL) has demonstrated resilience in the face of Monday’s setback concerning a potential blockbuster drug trial, showcasing an impressive 11% enhancement in underlying net earnings to $US2.017 billion ($A3.11 billion). Directors have concurrently exhibited confidence in the company’s trajectory by augmenting the interim dividend to $US1.19 per share, a notable increase